European Union · Question · QUESTION_WRITTEN
E-9-2021-000337
Safety of the BNT162b2 vaccine
Introduced
20 January 2021
Last action
16 March 2021 · Answer
Status
answered
Sponsors
Georg MAYER, Harald VILIMSKY, Roman HAIDER
Subjects
Discovery layer
Source updated
16 March 2021
Records
Official question E-9-2021-000337 from European Union at European Parliament. Dated 20 January 2021. Status: answered.
Timeline
20 January 2021
Written question
Safety of the BNT162b2 vaccine
Source: QUESTION_WRITTEN
16 March 2021
Answer
Source: QUESTION_WRITTEN_ANSWER
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
7 official files
Safety of BNT162b2 vaccine
QUESTION_WRITTEN · EN · 3 February 2021
Safety of BNT162b2 vaccine
QUESTION_WRITTEN · EN · 3 February 2021
Safety of BNT162b2 vaccine
QUESTION_WRITTEN · EN · 3 February 2021
Answer
QUESTION_WRITTEN_ANSWER · 16 March 2021
Sicherheit des Impfstoffs BNT162b2
QUESTION_WRITTEN · DE · 3 February 2021
Sicherheit des Impfstoffs BNT162b2
QUESTION_WRITTEN · DE · 3 February 2021
Sicherheit des Impfstoffs BNT162b2
QUESTION_WRITTEN · DE · 3 February 2021
Sponsors
- Georg MAYER · AUTHOR
- · EU_COMMISSION · ADDRESSEE
- Harald VILIMSKY · AUTHOR
- Roman HAIDER · AUTHOR
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.europarl.europa.eu/doceo/document/E-9-2021-000337_EN.html
- Open data entity: https://data.europarl.europa.eu/api/v2/parliamentary-questions/E-9-2021-000337
- eu · E-9-2021-000337 · source updated 16 March 2021